UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000003893
Receipt number R000004686
Scientific Title Aggressive choresterol lowing therapy by strong statin from acute phase of acute myocardial infarction.
Date of disclosure of the study information 2010/07/12
Last modified on 2013/06/24 20:53:53

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Aggressive choresterol lowing therapy by strong statin from acute phase of acute myocardial infarction.

Acronym

ROYAL-AMI

Scientific Title

Aggressive choresterol lowing therapy by strong statin from acute phase of acute myocardial infarction.

Scientific Title:Acronym

ROYAL-AMI

Region

Japan


Condition

Condition

ST-segment elevation myocardial infarction

Classification by specialty

Cardiology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To establish the intensive choresterol lowing therapy by strong statin(rosuvastatin, atorvastatin) aiming cardiac or vascular protection and improvement of cardic function by evaluation of damaged myocardial marker, ultrasound cardiography, myocardial scintigram in patients with STEMI.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

MSI(myocardial salvage index) assessed by SPECT

Key secondary outcomes

Various parameters of echocardiography, BNP levels and CoQ10 levels


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

rosuvastatin

Interventions/Control_2

atorvastatin

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

90 years-old >=

Gender

Male and Female

Key inclusion criteria

Patients admitted with AMI and treated with PCI, accompanied with LDL-C level >70mg/dl.

Key exclusion criteria

1. Familial hyper cholesteremia
2. Cyclospolin taking
3. Liver dysfunction
4. Renal failure
5. Pregnancy or possible
6. Hypothyroidism
7. Hereditary muscle disease
8. Drug or alcohol addiction
9. Hemodynamical Unstable condition

Target sample size

100


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Hisao Ogawa

Organization

Kumamoto University School of Medicine

Division name

Department of Cardiovascular Medicine

Zip code


Address

Honjo 1-1-1, Kumamoto

TEL

096-373-5175

Email



Public contact

Name of contact person

1st name
Middle name
Last name Seigo Sugiyama

Organization

Kumamoto University School of Medicine

Division name

Department of Cardiovascular Medicine

Zip code


Address

Honjo 1-1-1, Kumamoto

TEL

096-373-5175

Homepage URL


Email

ssugiyam@kumamoto-u.ac.jp


Sponsor or person

Institute

Department of Cardiovascular Medicine
Kumamoto University School of Medicine

Institute

Department

Personal name



Funding Source

Organization

Research Fund Donation

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

熊本大学附属病院(熊本)、 福岡徳洲会病院(福岡)、大牟田天領病院(福岡)
熊本赤十字病院(熊本)


Other administrative information

Date of disclosure of the study information

2010 Year 07 Month 12 Day


Related information

URL releasing protocol


Publication of results

Partially published


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2008 Year 02 Month 18 Day

Date of IRB


Anticipated trial start date

2008 Year 09 Month 01 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2010 Year 07 Month 08 Day

Last modified on

2013 Year 06 Month 24 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000004686


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name